Inhibition of CXXC5 function reverses obesity‐related metabolic diseases
Abstract Background Metabolic diseases, including type 2 diabetes, have long been considered incurable, chronic conditions resulting from a variety of pathological conditions in obese patients. Growing evidence suggests the Wnt/β‐catenin pathway is a major pathway in adipose tissue remodelling, panc...
Main Authors: | Seol Hwa Seo, Eunhwan Kim, Soung‐Hoon Lee, Yong‐ho Lee, Dai Hoon Han, Hyesun Go, Je Kyung Seong, Kang‐Yell Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
Wiley
2022-04-01
|
Series: | Clinical and Translational Medicine |
Subjects: | |
Online Access: | https://doi.org/10.1002/ctm2.742 |
Similar Items
-
CXXC5 Mediates DHT-Induced Androgenetic Alopecia via PGD<sub>2</sub>
by: Yeong Chan Ryu, et al.
Published: (2023-02-01) -
Small molecule inhibitors of the Dishevelled‐CXXC5 interaction are new drug candidates for bone anabolic osteoporosis therapy
by: Hyun‐Yi Kim, et al.
Published: (2016-03-01) -
Inhibition of CXXC5 function rescues Alzheimer’s disease phenotypes by restoring Wnt/β-catenin signaling pathway
by: Minguen Yoon, et al.
Published: (2023-08-01) -
Signal integrator function of CXXC5 in Cancer
by: Zihao An, et al.
Published: (2025-01-01) -
Pyruvate Kinase M2 Promotes Hair Regeneration by Connecting Metabolic and Wnt/β-Catenin Signaling
by: Yeong Chan Ryu, et al.
Published: (2022-12-01)